跳至主要内容
临床试验/CTRI/2011/091/000099
CTRI/2011/091/000099已完成4 期

Sero-surveillance to assess Rubella susceptibility and assessment of immunogenicity andreactogenicity of Rubella vaccine (R-Vac®) in female students aged 18-24 years, of Symbiosis International University ( SIU).

Serum Institute of India Research Foundation Pune Hadapsar Pune0 个研究点目标入组 500 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Female students aged 18-24 years at the time of enrollment.
  • 2. Free of obvious health problems as established by medical history & clinical examination
  • before entering into the study.
  • 3. Written, Explained, Signed informed consent.

排除标准

  • 1. Use of any investigational or non-registered drug or vaccine other than the study vaccine during the study period.
  • 2. Administration of immunoglobulin or any blood products in last 3 months.
  • 3. History of significant and persistent hematological, hepatic, renal, cardiac, respiratory,
  • neurological disorders or seizure.
  • 4. Axillary temperature ≥ 38.5 ° C.
  • 5. Confirmed immunosuppression including HIV infection.
  • 6. Major congenital or hereditary immunodeficiency.
  • 7. Simultaneous participation in any other clinical study.

研究者

发起方
Serum Institute of India Research Foundation Pune Hadapsar Pune

相似试验